GlassScriptPhysician profile
Ryanleo Flores
NPI 1003415472
$2,759.53
in general payments reported to CMS, 2019-2025
11 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $122 · 2023: $252 · 2024: $1,050 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Consulting Fee: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.02 |
| Consulting Fee | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,124.88 | 2022-2025 | Descovy, Yeztugo, Biktarvy |
| Viiv Healthcare Company | $427.91 | 2023-2024 | Apretude |
| Amgen INC. | $265.95 | 2025 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $243.19 | 2025 | Airsupra, Breztri |
| Axsome Therapeutics, INC. | $121.83 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $121.75 | 2024 | Austedo Xr |
| Regeneron Healthcare Solutions, INC. | $120.08 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.46 | 2021 | |
| Phadia US INC. | $94.03 | 2025 | Immunocap |
| Glaxosmithkline, LLC. | $90.45 | 2025 | |
| Medicines360 | $30.00 | 2023 | Liletta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryanleo Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.